Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of ZN-c5 in Healthy Post-Menopausal Women
NCT04561752Phase 1Completed
- Sponsor
- Zeno Alpha, Inc.
- Start
- Nov 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ZN-c5 in breast cancer (2 arms), sponsored by Zeno Alpha, Inc. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to Time t, Maximum Plasma Concentration and 2 more. Started Nov 2020; status: completed.
02
Drugs
ZN-c5
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04561752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04561752.